Assembly Series: ‘ObamaCare’ expert Jonathan Gruber to discuss why health-care reform is needed

Just a few days after the Affordable Care Act’s mandatory insurance component becomes law, the principal architect of the Massachusetts health care system and chief advisor to President Obama’s plan will be on campus to explain how it works and how it will benefit society. MIT economist and renowned health care expert Jonathan Gruber will deliver an Assembly Series lecture on “Health Care Reform: What It Is, Why It’s Necessary, How It Works” at 6 p.m. Friday, October 4 in Brown Hall Room 100 on the Washington University Danforth Campus.

School of Medicine celebrates launch of Taylor Family Institute

The Department of Psychiatry is hosting a celebration Tuesday, Oct. 1, to mark the official launch of the Taylor Family Institute for Innovative Psychiatric Research. The institute, dedicated to advancing the science underlying the diagnosis and treatment of psychiatric illnesses, was created with a $20 million gift from Andy and Barbara Taylor and the Crawford Taylor Foundation. Pictured are institute investigators.

Alzheimer’s progression tracked prior to dementia

A long-term study of older adults led by Anne Fagan (right) has helped validate a new system for identifying and classifying older adults with preclinical Alzheimer’s disease. Many researchers think this stage of the disease, which can last a decade or more, is critical window for slowing or stopping Alzheimer’s treatments.

Washington People: Daniel Coyne, MD

Daniel Coyne, MD, specializes in the treatment of patients on dialysis. He’s a strong believer in seeing that patients’ interests are put first. That philosophy spurred him to fight against the overuse of the anti-anemia drug Epogen in dialysis patients. The drug increases the risk of heart attacks and strokes and at one time was one of the top-selling prescription medicines in the United States. 

New models of drug-resistant breast cancer hint at better treatments

Breast cancer that spreads to other organs is extremely difficult to treat. Doctors can buy patients time, but a cure remains elusive. Now, researchers at the School of Medicine have shown that human breast tumors transplanted into mice are excellent models of metastatic cancer and could be valuable tools in the search for better treatments. Shown are human breast cancer cells (red) growing amid mouse cells (green).

Students choose labs via scientific ‘speed dating’

Faculty members manned posters highlighting their research at a recent Division of Biology and Biomedical Sciences event geared toward helping graduate students meet faculty and learn about research before signing up for laboratory rotations. The event is an engaging step for students earning their PhDs or MD/PhDs through the Medical Scientist Training Program. Pictured is student Allyson Mayer visiting with Carlos Bernal-Mizrachi, MD, at the event.
Older Stories